Doximity (DOCS) Financials

$51.95 +0.31 (+0.59%)

Closing price 03:59 PM Eastern

Extended Trading

$51.96 +0.01 (+0.03%)

As of 04:15 PM Eastern

Annual Income Statements for Doximity

This table shows Doximity's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020
Period end date	3/31/2024	3/31/2023	3/31/2022	3/31/2021	3/31/2020
Net Income / (Loss) Attributable to Common Shareholders	148	113	133	22	11
Consolidated Net Income / (Loss)	148	113	155	50	30
Net Income / (Loss) Continuing Operations	148	113	155	50	30
Total Pre-Tax Income	185	133	114	58	24
Total Operating Income	164	125	114	53	22
Total Gross Profit	425	366	304	176	101
Total Revenue	475	419	344	207	116
Operating Revenue	475	419	344	207	116
Total Cost of Revenue	51	53	40	31	15
Operating Cost of Revenue	51	53	40	31	15
Total Operating Expenses	261	240	190	122	79
Selling, General & Admin Expense	38	37	36	16	7.44
Marketing Expense	133	124	92	62	39
Research & Development Expense	82	80	62	44	32
Restructuring Charge	7.94	0.00	0.00	-	-
Total Other Income / (Expense), net	21	8.05	0.47	4.47	1.35
Other Income / (Expense), net	21	8.05	0.47	4.47	1.35
Income Tax Expense	38	20	-41	7.56	-6.22
Net Income / (Loss) Attributable to Noncontrolling Interest	0.00	0.00	22	29	19
Basic Earnings per Share	$0.78	$0.58	$0.82	$0.29	$0.16
Weighted Average Basic Shares Outstanding	190.17M	193.18M	163.48M	74.34M	66.76M
Diluted Earnings per Share	$0.72	$0.53	$0.70	$0.23	$0.13
Weighted Average Diluted Shares Outstanding	205.73M	213.43M	191.02M	95.13M	81.71M
Weighted Average Basic & Diluted Shares Outstanding	185.43M	194.67M	193.11M	-	-

This table shows Doximity's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022	6/30/2022
Net Income / (Loss) Attributable to Common Shareholders	75	44	41	41	48	31	28	31	33	26	22
Consolidated Net Income / (Loss)	75	44	41	41	48	31	28	31	33	26	22
Net Income / (Loss) Continuing Operations	75	44	41	41	48	31	28	31	33	26	22
Total Pre-Tax Income	90	62	53	48	63	40	35	37	41	33	22
Total Operating Income	80	53	46	42	59	34	30	33	38	32	22
Total Gross Profit	154	123	113	105	123	101	95	97	102	89	78
Total Revenue	169	137	127	118	135	114	108	111	115	102	91
Operating Revenue	169	137	127	118	135	114	108	111	115	102	91
Total Cost of Revenue	14	14	14	13	12	13	13	14	14	13	13
Operating Cost of Revenue	14	14	14	13	12	13	13	14	14	13	13
Total Operating Expenses	74	70	67	64	65	67	66	64	63	57	56
Selling, General & Admin Expense	14	10	9.26	9.97	9.64	8.97	9.25	9.76	9.51	8.75	8.72
Marketing Expense	38	34	35	34	35	30	34	33	33	29	28
Research & Development Expense	22	23	23	20	20	20	22	22	21	19	19
Restructuring Charge	0.00	2.30	-	-	0.00	7.94	-	-	0.00	0.00	-
Total Other Income / (Expense), net	9.92	9.03	7.12	6.10	4.48	5.90	4.84	3.88	2.46	0.91	0.80
Income Tax Expense	15	18	12	7.34	15	9.09	6.12	6.05	7.48	6.71	0.10
Basic Earnings per Share	$0.40	$0.24	$0.22	$0.21	$0.26	$0.16	$0.15	$0.15	$0.17	$0.14	$0.12
Weighted Average Basic Shares Outstanding	187.16M	186.25M	185.61M	190.17M	186.31M	193.11M	194.52M	193.18M	192.81M	193.14M	192.95M
Diluted Earnings per Share	$0.37	$0.22	$0.21	$0.20	$0.24	$0.15	$0.13	$0.15	$0.16	$0.12	$0.10
Weighted Average Diluted Shares Outstanding	202.23M	200.41M	199.22M	205.73M	200.46M	209.01M	212.36M	213.43M	212.07M	213.95M	214.95M
Weighted Average Basic & Diluted Shares Outstanding	187.64M	186.69M	185.66M	185.43M	186.55M	185.91M	194.71M	194.67M	193.59M	192.49M	193.46M

This table details how cash moves in and out of Doximity's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020
Period end date	3/31/2024	3/31/2023	3/31/2022	3/31/2021	3/31/2020
Net Change in Cash & Equivalents	-61	45	46	18	15
Net Cash From Operating Activities	184	180	127	83	26
Net Cash From Continuing Operating Activities	184	180	127	83	26
Net Income / (Loss) Continuing Operations	148	113	155	50	30
Consolidated Net Income / (Loss)	148	113	155	50	30
Depreciation Expense	10	10	5.04	3.70	0.90
Amortization Expense	3.63	12	14	7.08	4.63
Non-Cash Adjustments To Reconcile Net Income	55	52	34	5.39	4.30
Changes in Operating Assets and Liabilities, net	-32	-7.08	-82	17	-13
Net Cash From Investing Activities	31	-60	-641	-70	-13
Net Cash From Continuing Investing Activities	31	-60	-641	-70	-13
Purchase of Property, Plant & Equipment	-5.80	-6.18	-5.70	-4.61	-4.24
Acquisitions	0.00	-54	0.00	-32	0.00
Purchase of Investments	-473	-191	-1,317	-79	-79
Sale and/or Maturity of Investments	510	190	682	41	70
Other Investing Activities, net	0.00	0.00	0.60	-0.01	0.00
Net Cash From Financing Activities	-277	-74	560	5.41	1.72
Net Cash From Continuing Financing Activities	-277	-74	560	5.41	1.72
Repurchase of Common Equity	-281	-85	-6.68	-3.49	0.00
Issuance of Common Equity	16	15	568	8.90	0.00
Other Financing Activities, net	-12	-3.82	-0.82	0.00	1.72
Cash Income Taxes Paid	51	5.23	0.21	5.97	1.24

This table details how cash moves in and out of Doximity's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022	6/30/2022
Net Change in Cash & Equivalents	-19	73	15	-26	15	-198	149	22	63	-36	-2.72
Net Cash From Operating Activities	65	68	41	64	50	13	57	47	49	40	45
Net Cash From Continuing Operating Activities	65	68	41	65	50	13	57	47	49	40	45
Net Income / (Loss) Continuing Operations	75	44	41	41	48	31	28	31	33	26	22
Consolidated Net Income / (Loss)	75	44	41	41	48	31	28	31	33	26	22
Depreciation Expense	2.66	2.61	2.56	2.55	2.51	2.60	2.60	2.71	2.62	2.59	2.37
Amortization Expense	-1.58	-0.98	0.37	0.83	-0.14	0.57	2.37	2.40	1.99	3.29	4.22
Non-Cash Adjustments To Reconcile Net Income	20	21	17	13	13	14	14	14	16	12	9.91
Changes in Operating Assets and Liabilities, net	-31	1.30	-20	7.61	-13	-35	9.43	-2.92	-5.17	-4.86	5.86
Net Cash From Investing Activities	-59	24	30	-76	40	-50	117	-13	13	-19	-42
Net Cash From Continuing Investing Activities	-59	24	30	-76	40	-50	117	-13	13	-19	-42
Purchase of Property, Plant & Equipment	-1.77	-1.54	-1.70	-1.63	-1.32	-1.28	-1.56	-1.03	-1.22	-1.82	-2.13
Purchase of Investments	-164	-197	-170	-192	-101	-145	-35	-60	-39	-82	-8.87
Sale and/or Maturity of Investments	107	223	202	117	143	96	154	48	54	66	23
Net Cash From Financing Activities	-25	-20	-57	-14	-76	-161	-26	-12	0.78	-57	-5.97
Net Cash From Continuing Financing Activities	-25	-20	-57	-14	-76	-161	-26	-12	0.78	-57	-5.97
Repurchase of Common Equity	-19	-23	-51	-18	-77	-164	-22	-15	-	-61	-8.87
Issuance of Common Equity	3.66	9.11	2.55	5.09	2.54	5.43	3.29	4.89	1.87	4.91	3.01
Other Financing Activities, net	-9.60	-5.83	-7.86	-1.42	-1.25	-2.12	-7.35	-1.47	-1.09	-1.15	-0.11
Cash Income Taxes Paid	14	9.08	13	13	8.93	29	0.00	2.73	2.38	0.12	0.00

This table presents Doximity's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021
Period end date	3/31/2024	3/31/2023	3/31/2022	3/31/2021
Total Assets	1,079	1,137	991	252
Total Current Assets	913	975	904	209
Cash & Equivalents	97	158	113	66
Short-Term Investments	666	683	685	76
Accounts Receivable	101	107	81	50
Prepaid Expenses	49	27	19	11
Plant, Property, & Equipment, net	12	11	8.49	7.60
Total Noncurrent Assets	154	150	79	35
Goodwill	68	68	19	19
Intangible Assets	27	32	7.91	9.60
Noncurrent Deferred & Refundable Income Taxes	45	35	49	2.11
Other Noncurrent Operating Assets	14	15	3.35	4.10
Total Liabilities & Shareholders' Equity	1,079	1,137	991	252
Total Liabilities	178	171	113	104
Total Current Liabilities	147	140	111	102
Accounts Payable	2.25	1.27	0.46	1.52
Accrued Expenses	44	31	25	16
Current Deferred Revenue	99	105	85	83
Other Current Liabilities	2.15	1.75	0.64	0.97
Total Noncurrent Liabilities	31	31	1.48	1.48
Noncurrent Deferred Revenue	0.21	0.20	0.08	0.22
Other Noncurrent Operating Liabilities	31	31	1.40	1.26
Commitments & Contingencies	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	901	966	879	67
Total Preferred & Common Equity	901	966	879	67
Preferred Stock	0.00	0.00	0.00	0.00
Total Common Equity	901	966	879	67
Common Stock	824	762	703	30
Retained Earnings	80	218	191	36
Accumulated Other Comprehensive Income / (Loss)	-2.66	-14	-15	-0.02

This table presents Doximity's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2025	Q2 2025	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	12/31/2023	9/30/2023	6/30/2023	12/31/2022	9/30/2022	6/30/2022	12/31/2021
Total Assets	1,172	1,119	1,073	1,001	1,026	1,154	1,067	1,028	1,051	932
Total Current Assets	1,013	958	908	841	863	990	899	848	874	858
Cash & Equivalents	165	184	111	123	108	307	136	74	110	85
Short-Term Investments	680	621	639	587	621	566	665	676	666	680
Accounts Receivable	138	125	121	98	97	93	75	79	76	70
Prepaid Expenses	30	27	37	27	33	20	17	16	18	18
Plant, Property, & Equipment, net	13	13	13	12	12	12	12	12	11	8.22
Total Noncurrent Assets	146	148	152	148	151	152	157	169	165	66
Goodwill	68	68	68	68	68	68	68	68	68	19
Intangible Assets	24	25	26	28	29	31	33	34	35	8.80
Noncurrent Deferred & Refundable Income Taxes	43	44	45	37	39	39	40	51	49	35
Other Noncurrent Operating Assets	11	11	13	14	14	15	16	16	13	2.43
Total Liabilities & Shareholders' Equity	1,172	1,119	1,073	1,001	1,026	1,154	1,067	1,028	1,051	932
Total Liabilities	141	157	160	136	154	163	137	149	149	93
Total Current Liabilities	116	132	135	105	123	133	106	118	121	92
Accounts Payable	1.64	2.77	1.66	1.88	0.71	0.58	1.60	1.11	0.92	1.23
Accrued Expenses	43	34	28	34	29	32	33	26	25	24
Current Deferred Revenue	69	94	103	67	91	98	70	90	94	66
Other Current Liabilities	2.26	2.22	2.19	2.11	1.94	2.05	1.46	1.01	0.68	0.93
Total Noncurrent Liabilities	25	25	25	31	31	30	31	31	28	1.61
Noncurrent Deferred Revenue	0.07	0.15	0.12	0.17	0.24	0.19	0.14	0.17	0.20	0.04
Other Noncurrent Operating Liabilities	25	25	24	25	31	30	31	31	28	1.57
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	1,031	961	914	865	871	991	930	879	902	839
Total Preferred & Common Equity	1,031	961	914	865	871	991	930	879	902	839
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	1,031	961	914	865	871	991	930	879	902	839
Common Stock	879	863	842	808	795	778	746	731	715	688
Retained Earnings	151	95	73	61	85	225	203	170	205	154
Accumulated Other Comprehensive Income / (Loss)	1.02	2.68	-1.01	-4.65	-8.93	-12	-19	-22	-18	-4.01

This table displays calculated financial ratios and metrics derived from Doximity's official financial filings.

Metric	2024	2023	2022	2021	2020
Period end date	3/31/2024	3/31/2023	3/31/2022	3/31/2021	3/31/2020
Growth Metrics	-	-	-	-	-
Revenue Growth	13.45%	21.98%	66.05%	77.76%	0.00%
EBITDA Growth	28.17%	16.68%	94.21%	136.03%	0.00%
EBIT Growth	39.09%	16.80%	97.35%	145.68%	0.00%
NOPAT Growth	23.20%	-31.23%	232.73%	65.29%	0.00%
Net Income Growth	30.81%	-27.11%	208.27%	68.85%	0.00%
EPS Growth	35.85%	-24.29%	204.35%	76.92%	0.00%
Operating Cash Flow Growth	2.50%	41.89%	52.55%	216.70%	0.00%
Free Cash Flow Firm Growth	91.01%	-22.65%	95.10%	0.00%	0.00%
Invested Capital Growth	10.69%	55.46%	1,320.17%	0.00%	0.00%
Revenue Q/Q Growth	1.51%	4.31%	8.52%	0.00%	0.00%
EBITDA Q/Q Growth	16.78%	9.02%	5.32%	0.00%	0.00%
EBIT Q/Q Growth	19.59%	10.79%	4.41%	0.00%	0.00%
NOPAT Q/Q Growth	6.58%	-7.75%	11.00%	0.00%	0.00%
Net Income Q/Q Growth	7.23%	-5.10%	10.92%	0.00%	0.00%
EPS Q/Q Growth	7.46%	-5.36%	2.94%	0.00%	0.00%
Operating Cash Flow Q/Q Growth	10.38%	-0.18%	8.03%	0.00%	0.00%
Free Cash Flow Firm Q/Q Growth	20.39%	4.07%	0.00%	0.00%	0.00%
Invested Capital Q/Q Growth	-10.29%	-3.17%	9.84%	0.00%	0.00%
Profitability Metrics	-	-	-	-	-
Gross Margin	89.34%	87.24%	88.42%	84.92%	87.20%
EBITDA Margin	41.88%	37.07%	38.75%	33.13%	24.95%
Operating Margin	34.47%	29.86%	33.05%	25.76%	19.04%
EBIT Margin	38.96%	31.78%	33.18%	27.92%	20.20%
Profit (Net Income) Margin	31.04%	26.92%	45.05%	24.27%	25.55%
Tax Burden Percent	79.69%	84.73%	135.77%	86.92%	126.47%
Interest Burden Percent	100.00%	100.00%	100.00%	100.00%	100.00%
Effective Tax Rate	20.31%	15.27%	-35.77%	13.08%	-26.47%
Return on Invested Capital (ROIC)	99.08%	103.11%	357.86%	1,635.02%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	96.96%	102.28%	357.73%	1,629.58%	0.00%
Return on Net Nonoperating Assets (RNNOA)	-83.27%	-90.88%	-327.72%	-1,567.26%	0.00%
Return on Equity (ROE)	15.81%	12.23%	30.15%	67.76%	0.00%
Cash Return on Invested Capital (CROIC)	88.93%	59.69%	184.18%	1,435.02%	0.00%
Operating Return on Assets (OROA)	16.71%	12.51%	18.34%	22.95%	0.00%
Return on Assets (ROA)	13.32%	10.60%	24.90%	19.95%	0.00%
Return on Common Equity (ROCE)	15.81%	12.23%	27.76%	30.52%	0.00%
Return on Equity Simple (ROE_SIMPLE)	16.37%	11.68%	17.62%	75.23%	0.00%
Net Operating Profit after Tax (NOPAT)	131	106	154	46	28
NOPAT Margin	27.47%	25.30%	44.87%	22.39%	24.08%
Net Nonoperating Expense Percent (NNEP)	2.12%	0.83%	0.14%	5.45%	0.00%
Cost of Revenue to Revenue	10.66%	12.76%	11.58%	15.08%	12.80%
SG&A Expenses to Revenue	7.96%	8.77%	10.41%	7.97%	6.39%
R&D to Revenue	17.24%	19.14%	18.15%	21.21%	27.87%
Operating Expenses to Revenue	54.87%	57.38%	55.37%	59.16%	68.16%
Earnings before Interest and Taxes (EBIT)	185	133	114	58	24
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	199	155	133	69	29
Valuation Ratios	-	-	-	-	-
Price to Book Value (P/BV)	5.57	6.49	11.34	9.08	0.00
Price to Tangible Book Value (P/TBV)	6.23	7.24	11.70	15.85	0.00
Price to Revenue (P/Rev)	10.56	14.96	29.01	2.93	5.21
Price to Earnings (P/E)	34.02	55.56	74.78	28.10	55.94
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	2.94%	1.80%	1.34%	3.56%	1.79%
Enterprise Value to Invested Capital (EV/IC)	30.74	43.38	113.91	96.12	0.00
Enterprise Value to Revenue (EV/Rev)	8.95	12.95	26.68	2.63	0.00
Enterprise Value to EBITDA (EV/EBITDA)	21.38	34.94	68.86	7.95	0.00
Enterprise Value to EBIT (EV/EBIT)	22.99	40.76	80.41	9.43	0.00
Enterprise Value to NOPAT (EV/NOPAT)	32.60	51.20	59.47	11.76	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	23.13	30.22	72.43	6.57	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	36.32	88.45	115.56	13.40	0.00
Leverage & Solvency	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-0.86	-0.89	-0.92	-0.96	0.00
Leverage Ratio	1.19	1.15	1.21	1.70	0.00
Compound Leverage Factor	1.19	1.15	1.21	1.70	0.00
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	54.96%	0.00%
Common Equity to Total Capital	100.00%	100.00%	100.00%	45.04%	0.00%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	18.89	23.93	54.98	5.80	0.00
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	7.93%	54.96%	0.00%
Liquidity Ratios	-	-	-	-	-
Current Ratio	6.20	6.99	8.12	2.05	0.00
Quick Ratio	5.87	6.80	7.90	1.89	0.00
Cash Flow Metrics	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	117	61	79	41	0.00
Operating Cash Flow to CapEx	3,173.52%	2,904.30%	2,221.78%	1,799.85%	617.32%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-
Asset Turnover	0.43	0.39	0.55	0.82	0.00
Accounts Receivable Turnover	4.56	4.46	5.23	4.11	0.00
Inventory Turnover	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	40.30	42.40	42.71	27.23	0.00
Accounts Payable Turnover	28.75	61.66	40.23	20.59	0.00
Days Sales Outstanding (DSO)	79.99	81.93	69.80	88.77	0.00
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	12.70	5.92	9.07	17.73	0.00
Cash Conversion Cycle (CCC)	67.29	76.01	60.73	71.05	0.00
Capital & Investment Metrics	-	-	-	-	-
Invested Capital	138	125	80	5.67	0.00
Invested Capital Turnover	3.61	4.08	7.98	73.02	0.00
Increase / (Decrease) in Invested Capital	13	45	75	5.67	0.00
Enterprise Value (EV)	4,257	5,427	9,167	545	0.00
Market Capitalization	5,020	6,268	9,966	606	606
Book Value per Share	$4.83	$4.99	$4.59	$0.90	$0.00
Tangible Book Value per Share	$4.32	$4.48	$4.45	$0.51	$0.00
Total Capital	901	966	879	148	0.00
Total Debt	0.00	0.00	0.00	0.00	0.00
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00
Net Debt	-763	-841	-798	-143	0.00
Capital Expenditures (CapEx)	5.80	6.18	5.70	4.61	4.24
Debt-free, Cash-free Net Working Capital (DFCFNWC)	2.79	-5.05	-5.26	-35	0.00
Debt-free Net Working Capital (DFNWC)	766	836	793	107	0.00
Net Working Capital (NWC)	766	836	793	107	0.00
Net Nonoperating Expense (NNE)	-17	-6.82	-0.64	-3.88	-1.71
Net Nonoperating Obligations (NNO)	-763	-841	-798	-143	0.00
Total Depreciation and Amortization (D&A)	14	22	19	11	5.53
Debt-free, Cash-free Net Working Capital to Revenue	0.59%	-1.21%	-1.53%	-17.00%	0.00%
Debt-free Net Working Capital to Revenue	161.06%	199.49%	230.78%	51.89%	0.00%
Net Working Capital to Revenue	161.06%	199.49%	230.78%	51.89%	0.00%
Earnings Adjustments	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.78	$0.58	$0.82	$0.00	$0.00
Adjusted Weighted Average Basic Shares Outstanding	190.17M	193.18M	163.48M	0.00	0.00
Adjusted Diluted Earnings per Share	$0.72	$0.53	$0.70	$0.00	$0.00
Adjusted Weighted Average Diluted Shares Outstanding	205.73M	213.43M	191.02M	0.00	0.00
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	185.43M	194.67M	193.11M	0.00	0.00
Normalized Net Operating Profit after Tax (NOPAT)	137	106	79	46	16
Normalized NOPAT Margin	28.80%	25.30%	23.13%	22.39%	13.33%
Pre Tax Income Margin	38.96%	31.78%	33.18%	27.92%	20.20%
Debt Service Ratios	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	190.21%	75.63%	4.32%	6.95%	0.00%

This table displays calculated financial ratios and metrics derived from Doximity's official financial filings.

Metric	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022	6/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	24.63%	20.44%	16.79%	6.39%	17.37%	11.18%	19.67%	18.49%	17.76%	28.78%	24.73%
EBITDA Growth	32.95%	48.20%	41.34%	19.19%	41.39%	-2.68%	22.57%	14.54%	7.23%	25.57%	-4.40%
EBIT Growth	36.50%	57.26%	55.15%	27.44%	52.14%	5.27%	36.90%	17.69%	7.47%	26.53%	-12.99%
NOPAT Growth	50.17%	44.87%	46.74%	29.23%	41.61%	1.86%	13.17%	-25.35%	-43.44%	-27.94%	-17.86%
Net Income Growth	56.80%	44.28%	45.66%	32.44%	43.29%	16.36%	26.91%	-16.50%	-39.86%	-27.13%	-14.96%
EPS Growth	54.17%	46.67%	61.54%	33.33%	50.00%	25.00%	30.00%	-16.67%	-38.46%	-29.41%	11.11%
Operating Cash Flow Growth	30.24%	429.90%	-27.90%	37.10%	2.79%	-67.36%	27.82%	-0.69%	78.48%	106.32%	34.90%
Free Cash Flow Firm Growth	81.08%	76.84%	-129.46%	228.28%	179.16%	118.25%	131.98%	54.80%	-38.68%	-1,414.45%	-521.52%
Invested Capital Growth	20.60%	9.90%	38.67%	10.69%	19.48%	9.80%	-6.59%	55.46%	76.35%	331.36%	6,201.90%
Revenue Q/Q Growth	23.22%	8.02%	7.30%	-12.73%	19.08%	4.74%	-2.25%	-3.73%	12.80%	12.74%	-3.22%
EBITDA Q/Q Growth	47.86%	11.84%	8.29%	-25.76%	64.82%	6.66%	-8.68%	-11.93%	13.45%	34.33%	-14.66%
EBIT Q/Q Growth	50.40%	15.39%	10.04%	-28.52%	73.27%	13.84%	-9.62%	-14.66%	19.88%	48.05%	-22.30%
NOPAT Q/Q Growth	77.25%	5.31%	1.10%	-20.42%	71.00%	6.66%	-10.96%	-12.80%	22.99%	18.50%	-41.27%
Net Income Q/Q Growth	70.30%	6.71%	1.87%	-15.30%	56.71%	7.73%	-7.38%	-8.37%	27.26%	17.50%	-39.05%
EPS Q/Q Growth	68.18%	4.76%	5.00%	-16.67%	60.00%	15.38%	-13.33%	-6.25%	33.33%	20.00%	-44.44%
Operating Cash Flow Q/Q Growth	-4.62%	65.72%	-35.50%	27.75%	288.08%	-77.45%	22.64%	-4.23%	23.24%	-11.70%	-4.71%
Free Cash Flow Firm Q/Q Growth	47.97%	346.05%	-143.67%	13.88%	44.50%	-59.02%	290.19%	29.73%	66.69%	28.18%	-168.82%
Invested Capital Q/Q Growth	19.62%	-4.57%	17.76%	-10.29%	9.01%	20.40%	-6.00%	-3.17%	0.18%	2.43%	56.45%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	91.59%	90.01%	89.30%	89.36%	90.99%	88.77%	87.87%	87.67%	88.27%	87.07%	85.57%
EBITDA Margin	48.04%	40.03%	38.67%	38.31%	45.03%	32.54%	31.95%	34.20%	37.38%	37.17%	31.19%
Operating Margin	47.40%	38.84%	36.36%	35.45%	43.28%	29.74%	27.37%	29.60%	33.39%	31.41%	23.92%
EBIT Margin	47.40%	38.84%	36.36%	35.45%	43.28%	29.74%	27.37%	29.60%	33.39%	31.41%	23.92%
Profit (Net Income) Margin	44.60%	32.27%	32.66%	34.41%	35.45%	26.94%	26.19%	27.64%	29.04%	25.74%	24.69%
Tax Burden Percent	83.70%	71.02%	77.82%	84.70%	76.08%	77.09%	82.28%	83.53%	81.74%	79.67%	99.54%
Interest Burden Percent	112.41%	116.99%	115.45%	114.58%	107.65%	117.47%	116.30%	111.80%	106.39%	102.83%	103.71%
Effective Tax Rate	16.30%	28.98%	22.18%	15.30%	23.92%	22.91%	17.72%	16.47%	18.26%	20.33%	0.46%
Return on Invested Capital (ROIC)	128.20%	95.92%	99.50%	108.31%	108.76%	75.98%	80.79%	100.77%	108.30%	121.10%	134.60%
ROIC Less NNEP Spread (ROIC-NNEP)	127.13%	95.08%	98.82%	107.67%	108.31%	75.37%	80.31%	100.38%	108.04%	121.01%	134.49%
Return on Net Nonoperating Assets (RNNOA)	-104.29%	-79.66%	-84.26%	-92.47%	-91.20%	-63.72%	-69.98%	-89.19%	-95.67%	-109.36%	-123.94%
Return on Equity (ROE)	23.91%	16.26%	15.25%	15.84%	17.56%	12.27%	10.81%	11.58%	12.62%	11.74%	10.66%
Cash Return on Invested Capital (CROIC)	84.54%	93.87%	68.75%	88.93%	68.66%	71.44%	96.29%	59.69%	58.24%	50.29%	39.51%
Operating Return on Assets (OROA)	24.01%	18.72%	16.12%	15.21%	19.61%	12.98%	10.85%	11.65%	13.42%	12.73%	9.19%
Return on Assets (ROA)	22.59%	15.56%	14.48%	14.76%	16.06%	11.76%	10.38%	10.88%	11.67%	10.43%	9.49%
Return on Common Equity (ROCE)	23.91%	16.26%	15.25%	15.84%	17.56%	12.27%	10.81%	11.58%	12.62%	11.74%	10.66%
Return on Equity Simple (ROE_SIMPLE)	19.53%	18.11%	17.57%	0.00%	15.92%	14.13%	11.99%	0.00%	12.78%	16.05%	16.72%
Net Operating Profit after Tax (NOPAT)	67	38	36	35	45	26	24	27	31	26	22
NOPAT Margin	39.68%	27.58%	28.29%	30.03%	32.93%	22.93%	22.52%	24.72%	27.29%	25.03%	23.81%
Net Nonoperating Expense Percent (NNEP)	1.07%	0.84%	0.68%	0.64%	0.45%	0.62%	0.48%	0.39%	0.26%	0.10%	0.11%
Return On Investment Capital (ROIC_SIMPLE)	6.49%	-	-	-	5.15%	-	-	-	-	-	-
Cost of Revenue to Revenue	8.41%	9.99%	10.70%	10.64%	9.01%	11.23%	12.13%	12.33%	11.74%	12.93%	14.43%
SG&A Expenses to Revenue	8.06%	7.38%	7.31%	8.45%	7.13%	7.89%	8.53%	8.79%	8.25%	8.56%	9.63%
R&D to Revenue	13.30%	16.98%	17.82%	17.07%	14.74%	17.57%	20.22%	19.41%	17.80%	18.70%	20.99%
Operating Expenses to Revenue	44.18%	51.17%	52.95%	53.90%	47.71%	59.03%	60.51%	58.08%	54.88%	55.66%	61.65%
Earnings before Interest and Taxes (EBIT)	80	53	46	42	59	34	30	33	38	32	22
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	81	55	49	45	61	37	35	38	43	38	28
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	9.67	8.42	5.68	5.57	6.03	4.74	6.68	6.49	6.94	6.65	7.45
Price to Tangible Book Value (P/TBV)	10.61	9.32	6.33	6.23	6.79	5.34	7.42	7.24	7.79	7.53	8.42
Price to Revenue (P/Rev)	18.12	15.65	10.51	10.56	11.13	9.22	15.16	14.96	16.08	15.21	18.60
Price to Earnings (P/E)	49.50	46.46	32.30	34.02	37.88	33.55	55.73	55.56	57.20	43.27	46.41
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	2.02%	2.15%	3.10%	2.94%	2.64%	2.98%	1.79%	1.80%	1.75%	2.31%	2.15%
Enterprise Value to Invested Capital (EV/IC)	49.00	46.80	27.20	30.74	29.17	24.02	48.88	43.38	43.80	39.52	47.24
Enterprise Value to Revenue (EV/Rev)	16.58	14.09	8.99	8.95	9.61	7.59	13.16	12.95	14.09	13.26	16.45
Enterprise Value to EBITDA (EV/EBITDA)	39.66	34.70	23.09	21.38	26.41	22.29	37.41	34.94	39.71	36.52	45.26
Enterprise Value to EBIT (EV/EBIT)	41.28	36.49	24.61	22.99	29.07	25.24	43.19	40.76	47.08	43.38	53.90
Enterprise Value to NOPAT (EV/NOPAT)	51.90	47.44	31.25	32.60	36.75	31.13	52.77	51.20	49.25	36.66	39.87
Enterprise Value to Operating Cash Flow (EV/OCF)	38.21	32.58	26.38	23.13	27.00	20.56	29.94	30.22	31.45	32.15	43.05
Enterprise Value to Free Cash Flow (EV/FCFF)	63.37	52.21	45.97	36.32	46.25	35.20	49.04	88.45	95.97	127.57	235.37
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-0.82	-0.84	-0.85	-0.86	-0.84	-0.85	-0.87	-0.89	-0.89	-0.90	-0.92
Leverage Ratio	1.15	1.17	1.17	1.19	1.15	1.17	1.16	1.15	1.13	1.15	1.15
Compound Leverage Factor	1.29	1.37	1.35	1.36	1.24	1.38	1.35	1.29	1.20	1.18	1.20
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	44.20	32.48	21.02	18.45	24.62	17.61	26.05	23.64	29.96	25.04	28.66
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	8.74	7.24	6.72	6.20	8.03	7.00	7.46	6.99	8.49	7.18	7.24
Quick Ratio	8.48	7.03	6.44	5.87	7.71	6.71	7.28	6.80	8.27	7.02	7.06
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	35	24	-9.64	22	19	13	33	-17	-24	-73	-102
Operating Cash Flow to CapEx	3,680.91%	4,429.42%	2,420.36%	3,913.34%	3,780.51%	1,008.44%	3,657.29%	4,545.71%	4,004.69%	2,174.68%	2,105.98%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.51	0.48	0.44	0.43	0.45	0.44	0.40	0.39	0.40	0.41	0.38
Accounts Receivable Turnover	4.68	4.66	4.62	4.56	5.43	5.08	5.17	4.46	5.55	5.70	5.93
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	43.46	42.02	40.28	40.30	40.10	38.27	37.96	42.40	40.70	39.12	37.98
Accounts Payable Turnover	30.70	29.84	45.64	28.75	29.72	58.37	71.52	61.66	36.40	52.08	24.82
Days Sales Outstanding (DSO)	77.98	78.39	79.06	79.99	67.20	71.83	70.57	81.93	65.73	64.06	61.59
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	11.89	12.23	8.00	12.70	12.28	6.25	5.10	5.92	10.03	7.01	14.70
Cash Conversion Cycle (CCC)	66.09	66.16	71.06	67.29	54.92	65.58	65.47	76.01	55.70	57.05	46.89
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	186	156	163	138	154	142	118	125	129	129	126
Invested Capital Turnover	3.23	3.48	3.52	3.61	3.30	3.31	3.59	4.08	3.97	4.84	5.65
Increase / (Decrease) in Invested Capital	32	14	45	13	25	13	-8.30	45	56	99	124
Enterprise Value (EV)	9,123	7,284	4,436	4,257	4,503	3,402	5,749	5,427	5,659	5,096	5,948
Market Capitalization	9,967	8,089	5,186	5,020	5,213	4,132	6,623	6,268	6,460	5,846	6,724
Book Value per Share	$5.52	$5.18	$4.93	$4.83	$4.65	$4.48	$5.09	$4.99	$4.83	$4.54	$4.67
Tangible Book Value per Share	$5.03	$4.68	$4.42	$4.32	$4.13	$3.98	$4.58	$4.48	$4.31	$4.02	$4.14
Total Capital	1,031	961	914	901	865	871	991	966	930	879	902
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	-845	-806	-750	-763	-710	-730	-873	-841	-801	-750	-776
Capital Expenditures (CapEx)	1.77	1.54	1.70	1.63	1.32	1.28	1.56	1.03	1.22	1.82	2.13
Debt-free, Cash-free Net Working Capital (DFCFNWC)	52	20	23	2.79	26	9.79	-16	-5.05	-8.33	-20	-23
Debt-free Net Working Capital (DFNWC)	897	825	773	766	736	740	857	836	793	730	753
Net Working Capital (NWC)	897	825	773	766	736	740	857	836	793	730	753
Net Nonoperating Expense (NNE)	-8.30	-6.41	-5.54	-5.17	-3.41	-4.55	-3.98	-3.24	-2.01	-0.72	-0.80
Net Nonoperating Obligations (NNO)	-845	-806	-750	-763	-710	-730	-873	-841	-801	-750	-776
Total Depreciation and Amortization (D&A)	1.07	1.64	2.93	3.38	2.37	3.17	4.97	5.11	4.61	5.88	6.59
Debt-free, Cash-free Net Working Capital to Revenue	9.43%	3.84%	4.60%	0.59%	5.53%	2.18%	-3.71%	-1.21%	-2.07%	-5.26%	-6.32%
Debt-free Net Working Capital to Revenue	163.01%	159.70%	156.63%	161.06%	157.18%	164.98%	196.15%	199.49%	197.30%	189.87%	208.40%
Net Working Capital to Revenue	163.01%	159.70%	156.63%	161.06%	157.18%	164.98%	196.15%	199.49%	197.30%	189.87%	208.40%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.40	$0.24	$0.22	$0.21	$0.26	$0.16	$0.15	$0.15	$0.17	$0.14	$0.12
Adjusted Weighted Average Basic Shares Outstanding	187.16M	186.25M	185.61M	190.17M	186.31M	193.11M	194.52M	193.18M	192.81M	193.14M	192.95M
Adjusted Diluted Earnings per Share	$0.37	$0.22	$0.21	$0.20	$0.24	$0.15	$0.13	$0.15	$0.16	$0.12	$0.10
Adjusted Weighted Average Diluted Shares Outstanding	202.23M	200.41M	199.22M	205.73M	200.46M	209.01M	212.36M	213.43M	212.07M	213.95M	214.95M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	187.64M	186.69M	185.66M	185.43M	186.55M	185.91M	194.71M	194.67M	193.59M	192.49M	193.46M
Normalized Net Operating Profit after Tax (NOPAT)	67	39	36	35	45	32	24	27	31	26	22
Normalized NOPAT Margin	39.68%	28.78%	28.29%	30.03%	32.93%	28.32%	22.52%	24.72%	27.29%	25.03%	23.81%
Pre Tax Income Margin	53.28%	45.44%	41.97%	40.62%	46.59%	34.94%	31.83%	33.09%	35.52%	32.30%	24.81%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	55.25%	96.91%	193.19%	190.21%	202.18%	163.60%	82.64%	75.63%	58.92%	49.66%	7.35%

Frequently Asked Questions About Doximity's Financials

When does Doximity's financial year end?

According to the most recent income statement we have on file, Doximity's fiscal year ends in March. Their fiscal year 2024 ended on March 31, 2024.

How has Doximity's net income changed over the last 4 years?

Doximity's net income appears to be on an upward trend, with a most recent value of $147.58 million in 2024, rising from $29.74 million in 2020. The previous period was $112.82 million in 2023. Check out Doximity's forecast to explore projected trends and price targets.

What is Doximity's operating income?

Doximity's total operating income in 2024 was $163.88 million, based on the following breakdown:

Total Gross Profit: $424.75 million
Total Operating Expenses: $260.88 million

How has Doximity revenue changed over the last 4 years?

Over the last 4 years, Doximity's total revenue changed from $116.39 million in 2020 to $475.42 million in 2024, a change of 308.5%.

How much debt does Doximity have?

Doximity's total liabilities were at $177.98 million at the end of 2024, a 4.2% increase from 2023, and a 71.9% increase since 2021.

How much cash does Doximity have?

In the past 3 years, Doximity's cash and equivalents has ranged from $66.39 million in 2021 to $158.03 million in 2023, and is currently $96.79 million as of their latest financial filing in 2024.

How has Doximity's book value per share changed over the last 4 years?

Over the last 4 years, Doximity's book value per share changed from 0.00 in 2020 to 4.83 in 2024, a change of 483.2%.

Related Companies

This page (NASDAQ:DOCS) was last updated on 5/29/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Doximity (DOCS) Financials

Frequently Asked Questions About Doximity's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Doximity (DOCS) Financials

Annual Income Statements for Doximity

Quarterly Income Statements for Doximity

Annual Cash Flow Statements for Doximity

Quarterly Cash Flow Statements for Doximity

Annual Balance Sheets for Doximity

Quarterly Balance Sheets for Doximity

Annual Metrics And Ratios for Doximity

Quarterly Metrics And Ratios for Doximity

Frequently Asked Questions About Doximity's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools